Mitoimmune Therapeutics Stock

Mito Immune Therapeutics is a drug research and development biotech company.

Sign up today and learn more about Mitoimmune Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Mitoimmune Therapeutics Stock

Funding History

April 2019$12.0B
February 2021$27.5B


Founder and CEO

Soon ha Kim


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: